Laurus Labs Limited
Laurus Labs Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: LAURUSLABS and BSE: 540222 (ISIN INE947Q01028).
It has a market capitalisation of ₹1.12 lakh crore, a last close of ₹2,069 on 2026-10-19, a one-year return of 129.9%.
Valuation: a price-to-earnings ratio of 102x, a price-to-book ratio of 21.07x, a dividend yield of 0.1%.
Profitability: return on equity of 18.2%, return on capital employed of 21.3%, an operating margin of 28.0%.
Growth: sales growth of 4.1% a year over three years, net profit growth of 4.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.45x, promoter holding of 27.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 1.12 L Cr |
| Last close | ₹2,069 |
| P/E (TTM) | 102x |
| P/B | 21.07x |
| Dividend yield | 0.1% |
| ROE (FY) | 18.2% |
| ROCE (FY) | 21.3% |
| Operating margin (TTM) | 28.0% |
| Sales growth, 3-year CAGR | 4.1% |
| Profit growth, 3-year CAGR | 4.0% |
| Debt / equity | 0.45x |
| Promoter holding | 27.5% |
| 1-year return | 129.9% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means